Tag: Antimicrobial Resistance

Antabio SAS Awarded $4.4m in Second Tranche Funding from CARB-X

antibiotic resistance
Antabio SAS, the biopharmaceutical company focused on developing a broad pipeline of antibacterial treatments against life threatening WHO critical priority pathogens, announces that it has been award...

Recipharm Joined AMR Industry Alliance to Help Tackle Growing Concerns over AMR

Global contract development and manufacturing organisation (CDMO) Recipharm has joined the AMR Industry Alliance to help tackle growing concerns around antimicrobial resistance (AMR). Recipharm joi...

EMA Showed Plan for Supporting Alternatives to Antimicrobials

european medicines agency
The EMA Committee for Medicinal Products for Veterinary Use (CVMP) has published a reflection paper on ways to promote authorization of alternatives to antimicrobials. CVMP used the reflection paper t...

ICMRA Called on Global Health Leaders to Address Growing Threat of Antimicrobial Resistance

antimicrobial resistance
The International Coalition of Medicines Regulatory Authorities (ICMRA) issued a statement calling on the industry, healthcare practitioners, researchers, and other global health leaders to address th...

Evotec SE and Lygature to Battle Together Against Antimicrobial Resistance

Antimicrobial resistance
Evotec SE and Lygature announced their cooperation in a new initiative for the development of novel antibacterial agents: Gram-Negative Antibacterials NOW. The new GNA NOW project, led by Evotec SE...

WHO Urges to Use New Antimicrobial Resistance Tool

WHO launched a global campaign urging governments to adopt a tool to reduce the spread of antimicrobial resistance, adverse events and costs. The AWaRe tool was developed by the WHO Essential Medic...

PhagoMed Biopharma receives ‘Phönix 2018’ award in Austria

Vienna-based Biotech company PhagoMed Biopharma was awarded the Austrian Entrepreneurship Award 'Phönix 2018' in the category “Start-Up International”.

Scientists made a leap forward in the decoding of multi-resistant pathogens

Researchers at the University of Tübingen and the German Center for Infection Research (DZIF) have achieved a breakthrough in the decoding of multi-resistant pathogens. According to a study publish...

Roivant Sciences licenses a novel investigational biologic from iNtRON Bio

Roivant Sciences and iNtRON Biotechnology announced that they have entered into a licensing agreement for SAL200, a novel investigational biologic for the treatment of infectious diseases.

The round table on antimicrobial resistance was held in Moscow

Antimicrobial resistance
The round table on "Interaction between animal and human AMR. Myths and Challenges of Using Antibiotics in Food Producing Animals" was held at the British Ambassador's residence in Moscow.

Researchers developed an AI approach to identify antibiotic resistance genes

Researchers at the University of California San Diego have developed an approach that uses machine learning to identify and predict which genes make infectious bacteria resistant to antibiotics.

Sales of veterinary antimicrobials in Europe decreased by about 20%

A new report published by European Medicines Agency (EMA) shows that the overall sales of veterinary antimicrobials across Europe have decreased by more than 20% between 2011 and 2016.

Boston Pharmaceuticals licenses three anti-infective programs from Novartis

antimicrobial resistance
Novartis has entered into a licensing and equity agreement with Boston Pharmaceuticals for the development of three novel anti-infective drug candidates.

GARDP and Novartis to cooperate on enhancing generic antibiotics

microbiology plates
The Global Antibiotic Research & Development Partnership (GARDP) and Novartis are joining forces to accelerate the development and availability of generic antibiotic treatments for children.

Genentech antibiotic displays high activity against superbugs

antibiotic resistance
Recently published findings demonstrate that optimized arylomycin analogues could translate into new therapies to address the growing threat of multidrug-resistant Gram-negative infections.

Natural blue clay minerals are effective against major bacterial infections

Researchers at Arizona State University and Mayo Clinic have found that at least one type of blue clay may help fight disease-causing bacteria in wounds, including antibiotic-resistant bacteria.